You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Details for New Drug Application (NDA): 021191

✉ Email this page to a colleague

« Back to Dashboard

NDA 021191 describes IMAGENT, which is a drug marketed by Vesselon Spv Llc and Alliance Pharm and is included in two NDAs. Additional details are available on the IMAGENT profile page.

The generic ingredient in IMAGENT is perflubron. Additional details are available on the perflubron profile page.

Summary for 021191

Tradename:	IMAGENT
Applicant:	Vesselon Spv Llc
Ingredient:	dimyristoyl lecithin; perflexane
Patents:	0

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INTRAVENOUS			Strength	0.92MG/VIAL;0.092MG/VIAL
Approval Date:	May 31, 2002	TE:		RLD:	No

Expired US Patents for NDA 021191

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Vesselon Spv Llc	IMAGENT	dimyristoyl lecithin; perflexane	INJECTABLE;INTRAVENOUS	021191-001	May 31, 2002	5,605,673	⤷ Start Trial
Vesselon Spv Llc	IMAGENT	dimyristoyl lecithin; perflexane	INJECTABLE;INTRAVENOUS	021191-001	May 31, 2002	5,798,091	⤷ Start Trial
Vesselon Spv Llc	IMAGENT	dimyristoyl lecithin; perflexane	INJECTABLE;INTRAVENOUS	021191-001	May 31, 2002	6,287,539	⤷ Start Trial
Vesselon Spv Llc	IMAGENT	dimyristoyl lecithin; perflexane	INJECTABLE;INTRAVENOUS	021191-001	May 31, 2002	6,280,705	⤷ Start Trial
Vesselon Spv Llc	IMAGENT	dimyristoyl lecithin; perflexane	INJECTABLE;INTRAVENOUS	021191-001	May 31, 2002	5,626,833	⤷ Start Trial
Vesselon Spv Llc	IMAGENT	dimyristoyl lecithin; perflexane	INJECTABLE;INTRAVENOUS	021191-001	May 31, 2002	5,720,938	⤷ Start Trial
Vesselon Spv Llc	IMAGENT	dimyristoyl lecithin; perflexane	INJECTABLE;INTRAVENOUS	021191-001	May 31, 2002	5,695,741	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.